FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and medicine. What is offered is ProThrThrLysThrTyrPheProHisPhe peptide, a based pharmaceutical composition which is used for antitumour immune response stimulation, and also to methods of treating a mammal and immune response modulation.
EFFECT: range of products for cancer treatment is extended.
19 cl, 49 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE STIMULATING ANTITUMOR IMMUNE RESPONSE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD FOR TREATMENT OF MAMMAL AND METHOD FOR MODULATION OF IMMUNE RESPONSE | 2002 |
|
RU2305107C2 |
COMPLEX FOR ENHANCING IMMUNE RESPONSE | 2019 |
|
RU2779622C2 |
APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
METHODS AND ANTIBODIES FOR IMMUNE RESPONSE MODULATION | 2016 |
|
RU2757489C2 |
DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES | 2007 |
|
RU2459631C2 |
NEW BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW APPLICATION | 2006 |
|
RU2423375C2 |
INTRACELLULAR DELIVERY OF BIOMOLECULES FOR IMMUNE RESPONSE MODULATION | 2019 |
|
RU2819143C2 |
STIMULATION OF IMMUNE RESPONSE BY ENANTIOMERS OF CATIONIC LIPIDS | 2009 |
|
RU2530555C2 |
CYTOMODULATING LIPOPHILIC PEPTIDES FOR MODULATION OF IMMUNE SYSTEM ACTIVITY AND SUPPRESSION OF INFLAMMATION | 1998 |
|
RU2214417C2 |
Authors
Dates
2011-07-27—Published
2002-07-11—Filed